Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C15H21NO2 |
| Molecular Weight | 247.3327 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H]1C[C@H](CC(C)(C)C1)OC(=O)C2=CC=CN=C2
InChI
InChIKey=GQSGZTBDVNUIQS-DGCLKSJQSA-N
InChI=1S/C15H21NO2/c1-11-7-13(9-15(2,3)8-11)18-14(17)12-5-4-6-16-10-12/h4-6,10-11,13H,7-9H2,1-3H3/t11-,13-/m1/s1
| Molecular Formula | C15H21NO2 |
| Molecular Weight | 247.3327 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Ciclonicate is a vasodilator and is used in cerebral and peripheral vascular disorders. Ciclonicate, given orally, markedly reduced basal and stimulated lipolysis. In 24-h-fasted rats its antilipolytic activity was long-lasting. Cyclonicate would influence not only triglyceride hydrolysis, but also free fatty acid utilization by adipose tissue.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:31:37 GMT 2025
by
admin
on
Mon Mar 31 18:31:37 GMT 2025
|
| Record UNII |
7H634NXI03
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QC04AC07
Created by
admin on Mon Mar 31 18:31:37 GMT 2025 , Edited by admin on Mon Mar 31 18:31:37 GMT 2025
|
||
|
WHO-ATC |
C04AC07
Created by
admin on Mon Mar 31 18:31:37 GMT 2025 , Edited by admin on Mon Mar 31 18:31:37 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000081888
Created by
admin on Mon Mar 31 18:31:37 GMT 2025 , Edited by admin on Mon Mar 31 18:31:37 GMT 2025
|
PRIMARY | |||
|
7H634NXI03
Created by
admin on Mon Mar 31 18:31:37 GMT 2025 , Edited by admin on Mon Mar 31 18:31:37 GMT 2025
|
PRIMARY | |||
|
m3538
Created by
admin on Mon Mar 31 18:31:37 GMT 2025 , Edited by admin on Mon Mar 31 18:31:37 GMT 2025
|
PRIMARY | Merck Index | ||
|
10444661
Created by
admin on Mon Mar 31 18:31:37 GMT 2025 , Edited by admin on Mon Mar 31 18:31:37 GMT 2025
|
PRIMARY | |||
|
C167024
Created by
admin on Mon Mar 31 18:31:37 GMT 2025 , Edited by admin on Mon Mar 31 18:31:37 GMT 2025
|
PRIMARY | |||
|
DB13709
Created by
admin on Mon Mar 31 18:31:37 GMT 2025 , Edited by admin on Mon Mar 31 18:31:37 GMT 2025
|
PRIMARY | |||
|
258-561-4
Created by
admin on Mon Mar 31 18:31:37 GMT 2025 , Edited by admin on Mon Mar 31 18:31:37 GMT 2025
|
PRIMARY | |||
|
SUB06243MIG
Created by
admin on Mon Mar 31 18:31:37 GMT 2025 , Edited by admin on Mon Mar 31 18:31:37 GMT 2025
|
PRIMARY | |||
|
DTXSID001023827
Created by
admin on Mon Mar 31 18:31:37 GMT 2025 , Edited by admin on Mon Mar 31 18:31:37 GMT 2025
|
PRIMARY | |||
|
C032821
Created by
admin on Mon Mar 31 18:31:37 GMT 2025 , Edited by admin on Mon Mar 31 18:31:37 GMT 2025
|
PRIMARY | |||
|
CICLONICATE
Created by
admin on Mon Mar 31 18:31:37 GMT 2025 , Edited by admin on Mon Mar 31 18:31:37 GMT 2025
|
PRIMARY | |||
|
53449-58-4
Created by
admin on Mon Mar 31 18:31:37 GMT 2025 , Edited by admin on Mon Mar 31 18:31:37 GMT 2025
|
PRIMARY | |||
|
3808
Created by
admin on Mon Mar 31 18:31:37 GMT 2025 , Edited by admin on Mon Mar 31 18:31:37 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104521
Created by
admin on Mon Mar 31 18:31:37 GMT 2025 , Edited by admin on Mon Mar 31 18:31:37 GMT 2025
|
PRIMARY | |||
|
3908
Created by
admin on Mon Mar 31 18:31:37 GMT 2025 , Edited by admin on Mon Mar 31 18:31:37 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
